悦康药业(688658) - 2022 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2022 was ¥900,836,570.89, representing a year-on-year increase of 2.48%[6] - The net profit attributable to shareholders was ¥63,467,735.64, showing a decline of 9.58% compared to the same period last year[6] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥57,015,244.60, down 14.92% year-on-year[6] - The basic earnings per share were ¥0.14, reflecting a decrease of 12.50% year-on-year[6] - Total operating revenue for Q1 2022 was CNY 900,836,570.89, an increase of 2.0% compared to CNY 879,074,205.93 in Q1 2021[31] - Net profit for Q1 2022 was CNY 63,971,233.59, a decrease of 9.3% from CNY 70,276,993.94 in Q1 2021[35] - Basic earnings per share for Q1 2022 were CNY 0.14, down from CNY 0.16 in Q1 2021[37] Research and Development - The total R&D investment amounted to ¥107,500,189.55, an increase of 192.96% year-on-year, accounting for 11.93% of operating revenue, up 7.76 percentage points[9] - Research and development expenses increased significantly to CNY 73,938,790.33 in Q1 2022, compared to CNY 32,487,090.30 in Q1 2021, representing a growth of 128.2%[35] Cash Flow and Liquidity - The net cash flow from operating activities was negative at -¥32,912,014.96, indicating a significant decrease compared to the previous year[6] - Cash flow from operating activities was CNY 1,056,790,930.07 in Q1 2022, compared to CNY 1,091,062,823.15 in Q1 2021, indicating a decrease of 3.1%[37] - Net cash flow from operating activities was -$32.91 million, a decrease from -$7.80 million in the previous period, indicating a worsening cash flow situation[40] - Total cash inflow from operating activities was approximately $1.10 billion, while cash outflow was about $1.13 billion, resulting in a net cash outflow of $32.91 million[40] - Cash flow from investing activities showed a net outflow of approximately $174.59 million, compared to a net outflow of $187.84 million in the previous period[40] - Cash flow from financing activities resulted in a net outflow of $9.09 million, an improvement from a net outflow of $97.80 million previously[42] - The ending balance of cash and cash equivalents was approximately $2.07 billion, down from $2.09 billion at the end of the previous period[42] Assets and Liabilities - The total assets at the end of the reporting period were ¥5,657,588,561.47, a decrease of 1.21% from the end of the previous year[9] - The company's cash and cash equivalents decreased to RMB 2,191,886,310.36 from RMB 2,436,137,019.63 year-over-year[23] - Accounts receivable decreased to RMB 729,164,856.71 from RMB 816,812,146.63, indicating a reduction of approximately 10.7%[26] - Inventory increased to RMB 748,319,393.88 from RMB 632,314,542.55, reflecting an increase of about 18.4%[26] - Total current liabilities decreased to RMB 1,496,389,165.67 from RMB 1,682,202,891.72, a reduction of approximately 11.0%[29] - The company's non-current assets totaled RMB 1,827,827,856.04, up from RMB 1,660,976,354.24, indicating an increase of about 10.1%[29] - The total liabilities decreased to RMB 1,641,949,396.89 from RMB 1,799,673,767.06, a decrease of approximately 8.8%[29] - The company reported a significant increase in other non-current assets, rising to RMB 137,889,369.57 from RMB 67,811,422.55, an increase of about 103.5%[26] - The company's total current assets decreased to RMB 3,829,760,705.43 from RMB 4,065,814,783.54, a decrease of approximately 5.8%[26] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 14,594[15] - The company's total equity attributable to shareholders reached CNY 4,011,137,843.58, up from CNY 3,923,740,371.80 in the previous year[31] Expenses - Total operating costs for Q1 2022 were CNY 841,629,577.42, up from CNY 800,319,681.90 in Q1 2021, reflecting a year-over-year increase of 5.5%[31] - The company reported a decrease in sales expenses to CNY 378,294,755.36 in Q1 2022 from CNY 391,028,556.61 in Q1 2021, a reduction of 3.2%[35] - Cash paid to employees increased to $116.30 million from $87.61 million, reflecting a significant rise in labor costs[40] - Cash paid for taxes decreased slightly to $113.88 million from $118.39 million, indicating a reduction in tax liabilities[40] - Cash paid for purchasing goods and services was approximately $341.23 million, up from $338.92 million, showing stable operational expenses[40]